APA (7th ed.) Citation

G. R. Gimatdinova, O. E. Danilova, I. L. Davydkin, O. A. Rubanenko, & T. Y. Stepanova. (2024). Assessment of Clinical and Diagnostic Indicators of Cardiovascular Toxicity in Patients with Non-Hodgkin's Lymphomas in the Course of Programmatic Antitumor Therapy. SINAPS LLC.

Chicago Style (17th ed.) Citation

G. R. Gimatdinova, O. E. Danilova, I. L. Davydkin, O. A. Rubanenko, and T. Y. Stepanova. Assessment of Clinical and Diagnostic Indicators of Cardiovascular Toxicity in Patients with Non-Hodgkin's Lymphomas in the Course of Programmatic Antitumor Therapy. SINAPS LLC, 2024.

MLA (9th ed.) Citation

G. R. Gimatdinova, et al. Assessment of Clinical and Diagnostic Indicators of Cardiovascular Toxicity in Patients with Non-Hodgkin's Lymphomas in the Course of Programmatic Antitumor Therapy. SINAPS LLC, 2024.